MT2A promotes angiogenesis in chronically ischemic brains through a copper–mitochondria regulatory mechanism
Abstract Background Approximately half of patients with chronic ischemic cerebrovascular disease (CICD) exhibit poor revascularization. Metallothionein 2 A (MT2A) has a high affinity for metal ions and is potentially capable of chelating toxic copper ions to alleviate the impairment of angiogenesis....
Saved in:
Main Authors: | Ni Mo, Chuyang Tai, Yang Yang, Cong Ling, Baoyu Zhang, Lei Wei, Cian Yao, Hui Wang, Chuan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-025-06163-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
by: Yating Cong, et al.
Published: (2025-01-01) -
Recent research progress on metal ions and metal-based nanomaterials in tumor therapy
by: Yongcheng Xu, et al.
Published: (2025-02-01) -
Cuproptosis Cell Death Molecular Events and Pathways to Liver Disease
by: Mao Y, et al.
Published: (2025-01-01) -
Comorbidities, long‐term outcome and poststroke epilepsy associated with ischemic stroke – A multicenter observational study of 125 dogs
by: Cecilia‐Gabriella Danciu, et al.
Published: (2025-01-01) -
The relationship between kidney disease and mitochondria: a bibliometric study
by: Jueyi Mao, et al.
Published: (2024-12-01)